Skip to main content
OpenTrials
Completed

NCT Number: NCT01134588

Assessment of Quality of Life in Disorders of the Pelvic Floor

The purpose of this study is to compare the touch-screen version of the PFDI-20, PFIQ-7, PISQ 12 and SF-36 french questionnaires to their paper versions. The investigators hypothesize that the percentage of completely filled questionnaires will be higher in the touch-screen version.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Centre Hospitalier Universitaire de Nîmes

Nîmes, 30029, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • the patient has pelvic organ prolapse
  • the patient requires a surgical intervention within the next 4 to 8 weeks
  • the patient understands and reads french
  • the patient is affiliated with a social security system
  • the patient has given consent

Exclusion criteria

  • the patient refuses to participate
  • the patient is under guardianship

Treatment and study plan

Paper questionnaire

Other

Touch screen questionnaire

Other

Primary outcomes

  1. Presence / absence of a completely filled out questionnaire

    Time frame: 6 months post-op

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nīmes

Other

Registry information

Acronym: U-GYN-QOL

Important dates

Study start
2010
Primary completion
2013
Study completion
2013
First posted
Jun 2, 2010
Registry last updated
Mar 25, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.